Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of Glypican-1 Expression in Pleural Epithelioid Mesothelioma, Adenocarcinoma and Squamous Cell Carcinoma of the Lung

NCT05228795 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05228795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05228795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of Glypican-1 Expression in Pleural Epithelioid Mesothelioma, Adenocarcinoma and Squamous Cell Carcinoma of the Lung
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2022
Completion date
December 1, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer adenocarcinoma, lung cancer squamous cell, mesothelioma; lung